Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1055957

registered interest
date	06/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Biosimilar Medicines
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps NHS Improvement is taking to ensure that hospital trusts across the NHS are following shared decision-making principles and patient consent guidance within NHS England's Commissioning framework for biological medicines (including biosimilar medicines) when implementing biosimilar switching programmes.
tabling member constituency	Bolton West
tabling member printed	Chris Green
uin	217622
answer	answer is ministerial correction date of answer 14/02/2019 answer text <p>NHS Improvement does not monitor use of shared decision making. It instead monitors uptake of the biosimilars as against the original – usually patented – medicines.</p><p> </p><p>It does, however, hold a joint role in supporting the National Health Service to use the best value biologic medicine which is part of a long standing programme of work connected to the NHS Biosimilar Medicines Programme Board, the NHS England Medicines Value Programme and the NHS Improvement Top 10 Medicines remit.</p><p> </p><p>The biosimilars medicines programme board is intended to ensure appropriate use of biosimilar medicines across the NHS in England. This includes shared decision making and patient consent and the board has produced guidance which sets out the importance of shared decision making which is fully endorsed by patient groups.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 14/02/2019 12:01:49 answering member 4067 label Biography information for Steve Brine
tabling member	4398 label Biography information for Chris Green

168702

registered interest
date	08/12/2014
answering body	Ministry of Justice
answering dept id	54
answering dept short name	Justice
answering dept sort name	Justice
hansard heading	Courts: Buildings
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Justice, pursuant to the Answer of 25 November 2014 to Question 215339, how many staff of (a) his Department and (b) external contractors are working on the detailed planning of the court reform programme.
tabling member constituency	Houghton and Sunderland South
tabling member printed	Bridget Phillipson
uin	217622
answer	answer is ministerial correction date of answer 13/01/2015 answer text <p /> <p>Resourcing for the HMCTS Reform Programme is appropriate for the stage the programme is at. A full resourcing plan is being developed as one of the components of the overall planning currently being undertaken, ahead of full programme mobilising in spring 2015. Current resourcing is allocated from across a number of different areas of MoJ and varies depending on the tasks the Programme is engaged in. External support for the programme is provided via a procured contractual package.</p> answering member constituency North West Cambridgeshire answering member printed Mr Shailesh Vara question first answered 13/01/2015 17:16:19 answering member 1496 label Biography information for Shailesh Vara
tabling member	4046 label Biography information for Bridget Phillipson